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Abstract Entamoeba histolytica, the etiological agent of am-
ebiasis, is a significant cause of pediatric diarrhea in South
Asia and sub-Saharan Africa. The clinical outcome of an E.
histolytica exposure varies enormously and can present as
diarrhea, dysentery, or amebic liver abscess. Host and parasite
factors likely contribute to the outcome of infection with the
parasite, but do not explain the wide variation in presentation
of disease. This suggests that other environmental factors af-
fect disease. An emerging body of work suggests that the host
intestinal bacterial microbiome may have a significant influ-
ence on the development and outcome of amebiasis.
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Introduction
It is estimated that 1 million children under the age of five die
from diarrhea each year. Population-based surveys of pediatric
diarrheal diseases have linked Entamoeba histolytica, the eti-
ological agent of amebiasis, to a significant number of diar-
rheal cases in South Asia and sub-Saharan Africa [1•]. The
outcome of an E. histolytica exposure varies tremendously
and can present as diarrhea, dysentery, or amebic liver ab-
scess, with liver disease occurring primarily in men [2].
Disease occurs relatively infrequently however, and many
cases of exposure are asymptomatic. Host and parasite factors
likely contribute to the outcome of infection with the parasite
[3, 4]. However, these factors do not fully explain the wide
variation in presentation in patients. Therefore, an environ-
mental factor likely contributes to the progression of E.
histolytica infection.
Initial infection with E. histolytica occurs after ingestion of
faecally contaminated water or food containing E. histolytica
cysts. These cysts then undergo excystation in the lumen of the
small intestine. The trophozoite stage of the ameba then feeds
on resident bacteria as well as the intestinal mucosa in severe
cases. Extraintestinal amebiasis occurs when the ameba invades
the intestinal mucosa and travels to the blood stream [3, 5]. This
manifests as liver or brain disease. In each case however, the
initial interaction of the ameba with the host occurs in the con-
text of the bacterial microbiota [6, 7•]. The microbiota, includ-
ing the normal flora of the human gastrointestinal tract, is a
complex community of bacteria that is composed of at least
several hundred species. Ultimately, there are considerably
more bacterial cells than there are eukaryotic cells in the human
body and these organisms form a symbiosis that influences
human physiology and disease progression [5, 8, 9]. This com-
munity of bacteria may have a significant influence on the
virulence of the amoeba itself, its ability to colonize the gut,
and the host’s immune response at baseline, and during amebi-
asis. The bacterial microbiota is therefore a significant environ-
mental factor that may influence the clinical presentation and
outcome of E. histolytica infections (Fig. 1).
The Microbiota and E. histolytica Virulence
Many factors contribute to virulence in E. histolytica infec-
tion. This includes parasite factors, such as surface lectins that
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bind oligosaccharides on intestinal mucins [10], and host fac-
tors such as genetic background, including polymorphisms in
the leptin receptor [11]. Coinfections with enteropathogens,
and nutritional state, particularly malnutrition, also influence
disease [1•, 10]. Marie et al. has recently provided an in depth
review of these, and other factors, that influence E. histolytica
virulence in human hosts and models of disease [7•]. Studies
in gnotobiotic animals have also indicated that commensal
bacteria are necessary for virulent E. histolytica infection
[12, 13]. A recent study by Reyna-Fabián et al has also sug-
gested that the host intestinal microbiota may influence the
parasite during one of the more severe forms of parasite infec-
tion, amebic liver abscesses (ALA) [14].
Reyna-Fabián et al. utilized 16S ribosomal RNA (rRNA)
gene sequencing to identify bacterial species and query bacte-
rial population diversity and phylogenetic relationships be-
tween organisms in liver aspirates from patients with ALA as
well as pyogenic liver abscess (PLA). They compared this with
clinical data that included the etiology (pyogenic, amebic, or
mixed) of the hepatic abscess as well as Entamoeba genotypes
and then performed statistical tests for significant associations.
Their results suggested that a high percentage of amebic liver
abscesses are co-infected with non-cultivable bacteria of the
intestinal microbiota, as well as potentially pathogenic bacteria.
However, they were not able to identify specific groups of
bacteria associated with any species or genotype of
E. histolytica or E. dispar in ALA [14]. Future studies with
larger population sizes may allow determination of which com-
ponents of the intestinal bacterial microbiota might correlate
with ALA. This work suggests however that the intestinal bac-
terial microbiota may interact with E. histolytica at extraintes-
tinal sites, perhaps via translocation with the ameba.
E. histolytica and the Composition of the Intestinal
Microbiota in Human Populations
Probiotics and commensal bacteria have been suggested to
have some influence on the outcome of protozoan infections
[15•]. However, very few studies have specifically examined
associations between Entamoeba infection and variation in the
human intestinal microbiota. E. histolytica colonization may
alter, or be influenced by, the ratio of bacterial phyla present in
the host microbiota. Verma et. al. demonstrated that
E. histolytica associated dysbiosis in northern India was char-
acterized by significantly less Clostridia, Bacteroides,
Lactobacillus, Campylobacter, and Eubacterium and in-
creased Bifidobacterium species in stool samples as compared
to healthy controls [16]. Commensal bacteria and components
of the microbiota generally exist in symbiosis with the host;
however, some normal flora have the potential to cause, or
exacerbate, existing disease. These commensals with patho-
genic potential are known as pathobionts [17].
Recently, Morton et al. characterized the fecal microbiota
of rural populations in southwest Cameroon via 16S rRNA
gene sequencing and determined Entamoeba colonization via
microscopy [18••]. The use of microscopy however does not
allow discrimination between intestinal amoeba E. dispar,
which is generally nonpathogenic, and E. histolytica, the caus-
ative agent of amebiasis [19, 20]. They discovered that
Entamoeba colonization is significantly correlated with
microbiome composition and diversity. Most interestingly,
they show that colonization by the amoeba can be predicted
based on the composition of an individual’s gut microbiota
with 79 % accuracy. Several of the taxa most important for
distinguishing Entamoeba presence, which included
Prevotella copri, are also associated with autoimmune dis-
eases [21]. P. copri can exist as a normal component of the
gut microbiota, but is also a pathobiont, and is associated with
more severe inflammation in several diseases [22]. This high-
lights the potential influence of inflammation driven by the
gut microbiome in altering amoeba infection.
Gilchrist et al. have just prospectively studied the natural
history of E. histolytica colonization and diarrhea in infants in
an urban slum located in Dhaka, Bangladesh. In this popula-
tion, approximately 80 % of children were infected with
E. histolytica by 2 years of age [23••]. High parasite burden
and expansion of P. copri was associated with diarrhea. This
work suggested that specific components of the microbiota and
pathobionts might be associated with symptomatic or asymp-
tomatic E. histolytica colonization. These studies, and future
microbiome studies, provide for a better understanding of envi-
ronmental factors that underlie the wide variation in clinical
presentation of E. histolytica infection. However, it is difficult
to test causality in population-based studies; therefore, disease
models provide a useful tool to understand how themicrobiome
may influence the progression and severity of ameba infection.
Fig. 1 Potential interactions between the microbiota and E. histolytica.
The intestinal bacterial microbiota may influence the virulence of the
ameba and its ability to colonize the gut (left), as well as the host’s
immune response at baseline, and during amebiasis (top). In turn, the
ameba infection may influence the composition of the microbiota,
resulting in dysbiosis (right), and may alter localization of the intestinal
microbiota (bottom). These factors may in turn influence the clinical
outcome of E.histolytica infection
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Microbiota Modulation of the Immune System
and Potential Influence on E. histolytica Infection
The intestinal bacterial microbiota has recently been shown to
be important in modulating bone marrow processes that give
rise to immune effector cells needed for pathogen clearance,
such as neutrophils and inflammatory macrophages, and in
providing protection from enteric infection [24, 25]. Several
studies have also suggested that intestinal infection with one
organism, or vaccination, may persistently alter innate im-
mune populations to provide protection from infection with
unrelated pathogens. This idea has been referred to as trained
immunity [26, 27•]. However, the mechanism of how unrelat-
ed organisms might generate this innate memory to provide
protection is not currently well understood. Murine models of
amebiasis provide a method to test how the intestinal micro-
biota may influence innate immune populations and subse-
quent infection with the parasite [28].
Recently, we have shown that mice colonized with the
commensal Clostridia, segmented filamentous bacteria
(SFB), are protected from experimental amebiasis. Bone mar-
row derived dendritic cells (BMDCs) from SFB colonized
mice produced significantly higher levels of interleukin 23
[29••]. IL-23 is a cytokine [30] linked to induction of IL-17
and neutrophils, which in turn have been shown to be impor-
tant in immunity to the ameba [31, 32]. Transfer of BMDCs
derived from mice colonized with SFB provided protection
from E. histolytica infection. A host damage associated mo-
lecular pattern molecule serum amyloid A (SAA) was also
increased in the serum of SFB colonized mice compared to
mice lacking the commensal. Treatment of BMDCswith SAA
partially recapitulated the effect of increased Interleukin 23
that was observed in BMDCs from SFB colonized mice
[29••]. This work suggested that gut colonization with a com-
mensal Clostridiamight alter bone marrow cells and that host
factors induced by the microbiota, such as SAA, might alter
the course of E. histolytica infection.
Therefore, trained immunity may provide another potential
pathway by which components of the bacterial intestinal mi-
crobiota could influence the outcome of amebiasis. Gut com-
mensals or pathobioants may serve to alter the immune system
in such a way that infection with E. histolytica results in a
more robust mucosal immune response. This robust response
could represent a doubled-edged sword; on one hand, it may
help to clear the ameba, as in our murine model, or it might
contribute to intestinal damage and more severe pathology
and colitis in patients.
Conclusions
Recent population-based and murine studies have highlighted
the importance of the intestinal bacterial microbiome and
E. histolytica infection. The microbiome and parasite may
interact in various ways, which may include alteration of vir-
ulence of the ameba, perhaps both in gut infections and in liver
abscesses, induction of colonization resistance, or dysbiosis
induced by the ameba, and modulation of host immunity,
which alters the outcome of parasite infection. Many ques-
tions remain however. It is not truly understood how
E. histolytica affects the composition of microbiota, or how
the microbiota in turn may influence the progression and se-
verity of amebiasis. Further exploration of interactions be-
tween the gut microbiome and E. histolytica will thus help
provide tools and approaches that will help in the diagnosis
and treatment of amebiasis.
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